FLIP: Preventing Diabetes in Those at Risk by Having a Facilitator and Family Doctor Encourage Healthy Activity and Eating Habits

Sponsor
University of British Columbia (Other)
Overall Status
Completed
CT.gov ID
NCT01589835
Collaborator
Canadian Institutes of Health Research (CIHR) (Other)
59
1
2

Study Details

Study Description

Brief Summary

Nearly six million Canadians are living with an increased risk of diabetes (prediabetes) and approximately 50% of these will develop type 2 diabetes within five years. The investigators wish to help these people change their lifestyle, to prevent them from getting diabetes. Trials have shown that by supporting people with prediabetes to be more active and have healthier eating habits they can halve their risk. However, these interventions were very costly and not performed in Canada. With the help of local Family Physicians and other health professionals (e.g. physiotherapy, psychology, endocrinology, nursing) the investigators have created a less expensive intervention suitable for the Canadian population and health system. The investigators need to perform a study to see whether these modified approaches are practical for Canadians and likely to be effective. People at risk will be invited to participate from family practices that have helped us in the initial stages of this program. Family practices will be randomized to giving either the study intervention or continue with the physician's usual care. People receiving the intervention will have an appointment with their family doctor to discuss their exercise and eating habits and agree changes that are necessary. A prescription detailing these changes will be completed and signed by the family physician and participant. Participants will be given the name of a lifestyle change facilitator (LCF) who will receive a copy of the prescription and contact the participant to help them set achievable goals. The LCF will contact participants once a month for six months to help them achieve these goals. The investigators eventual aim is to test this intervention in a large-scale randomized control trial. To achieve this it is necessary to pilot all aspects of the trial. Information from the pilot study can then be used to design and perform a large-scale study effectively. The investigators hope that eventually the numbers of Canadians progressing to having diabetes will be reduced.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Lifestyle changes
Phase 2

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Preventing Diabetes With Facilitated Lifestyle Intervention Prescriptions.Phase 2: Pilot Study
Study Start Date :
Jul 1, 2012
Actual Primary Completion Date :
Oct 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Lifestyle counseling

Green prescription with facilitator support

Behavioral: Lifestyle changes
Green prescription with support from facilitator

Other: Usual care

Behavioral: Lifestyle changes
Green prescription with support from facilitator

Outcome Measures

Primary Outcome Measures

  1. HbA1c Progression to diabetes [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults aged ≥ 18 years

  • HbA1c of 5.7 to 6.4% and/or FPG of 6.1 to 6.9 mmol/l and/or a 2hr 75g OGTT of between 7.8 and 11.0 mmol/l

Exclusion Criteria:
  • People with Type I or II diabetes

  • Unstable angina

  • Uncontrolled congestive heart failure

  • Unstable arrhythmia

  • Heart valvular disease

  • Severe hypertension (systolic ≥ 200 or diastolic ≥ 120)

  • Pregnant women or planning pregnancy within two years

  • Life expectancy < 1 year

  • Waiting for major surgery

  • High risk of fracture

  • Pregnancy or planning pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 UBC Family Practice Vancouver British Columbia Canada V6T 1Z3

Sponsors and Collaborators

  • University of British Columbia
  • Canadian Institutes of Health Research (CIHR)

Investigators

  • Principal Investigator: Martin Dawes, UBC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT01589835
Other Study ID Numbers:
  • H12-01330
First Posted:
May 2, 2012
Last Update Posted:
Mar 5, 2014
Last Verified:
Mar 1, 2014
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 5, 2014